NCT00767221View on ClinicalTrials.gov

Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
IGA Nephropathy
Interventions
DRUG

Budesonide

8 mg PL-56 once daily for six months

Trial Locations (3)

Unknown

Linköping University Hospital, Linköping

Huddinge University Hospital, Stockholm

Uppsala University Hospital, Uppsala

Sponsors
All Listed Sponsors
collaborator

Archimedes Development Ltd

INDUSTRY

lead

Calliditas Therapeutics AB

INDUSTRY